Jan 16 (Reuters) - Swiss online drug retailer DocMorris
DOCM.S reported higher fourth quarter external revenue as it
continues to aim for profitability on an adjusted core earnings
basis, excluding e-prescriptions, in 2024.
DocMorris' external revenue in the fourth quarter rose 10.8%
year-on-year to 280.5 million Swiss francs ($326.66 million),
1.6% above analysts' estimate of 276 million Swiss francs in a
company-compiled consensus.
($1 = 0.8587 Swiss francs)
(Reporting by Tristan Veyet and and Chiara Holzhaeuser in
Gdansk; Editing by Christian Schmollinger)
((Tristan.Chabba@thomsonreuters.com;
Chiara.Holzhaeuser@thomsonreuters.com))